Amgen (AMGN) closed at $366.44 in the latest trading session, marking a -2.06% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.72%. Elsewhere, the Dow gained 0.

Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...

By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...

If you are wondering whether Amgen stock still offers value at current levels, this article walks through what the numbers ...

Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate ...

By Jonathan Stempel July 1 (Reuters) - A federal judge on Wednesday blocked Colorado from capping the price of Amgen's ...

Viridian Therapeutics has scored an FDA approval for Lumvoa to treat thyroid eye disease (TED), triggering competition with ...

The tablets involved in the recall were distributed in the U.S. from Oct. 28, 2021, to Dec. 30, 2025 ...

Amgen recalls 934K bottles of Corlanor and Sensipar due to foreign material and manufacturing deviations, per FDA June 23 report.

Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...

Amgen announced 52-week results from a phase 2 trial with its weight-management candidate, MariTide. The results Amgen posted don't appear very competitive with Eli Lilly's weight management drug, ...

Amgen (AMGN) stock is in focus as an expert panel of the European Medicines Agency recommends withdrawal of the company's ...